Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis

NCT02366325 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Renal Failure
Anemia

Interventions

DRUG: EPO-018B

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.